News
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it ...
Request To Download Free Sample of This Strategic Report @- Cardiovascular genetic testing enables clinicians and patients to identify inherited risks for a wide range of cardiac disorders, including ...
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.
StockStory.org on MSN10d
Therapeutics Stocks Q1 Teardown: Amgen (NASDAQ:AMGN) Vs The RestThe end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else ...
StockStory.org on MSN15d
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To KnowWhat Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market ...
My plan is to tell my siblings, aunts and uncles that we have a sufficient history of cancer in our family to qualify for genetic testing and that they should discuss it with their doctors if ...
Ancient DNA has revealed links between the cultures of Egypt and Mesopotamia. Researchers sequenced whole genomes from the teeth of a well-preserved skeleton found in a sealed funeral pot in an ...
The DNA data of millions of people who used 23andMe's services won't be sold to a pharmaceutical company. A bankruptcy judge greenlighted the sale of the remnants of the firm, including its wealth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results